Plasbumin 2.5 g/50mL (Albumin (Human) SOLUTION) 2.5 g/50mL

Plasbumin 2.5 g/50mL is a human albumin solution used for volume expansion and to treat low protein levels. This intravenous solution is manufactured by Grifols USA, LLC.

Strength

2.5 g/50mL

Pack Size

1 VIAL in 1 CARTON (13533-690-20) / 50 mL in 1 VIAL (13533-690-21)

Manufacturer / TM Owner

GRIFOLS USA, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Plasbumin 2.5 g/50mL is primarily used to increase blood volume in conditions where fluid replacement is needed. It is also used to treat hypoproteinemia, a condition characterized by low protein levels in the blood. This solution helps maintain proper blood pressure and circulation, supporting overall bodily functions.

Side Effects

When administered intravenously, Plasbumin 2.5 g/50mL works by expanding blood volume and increasing protein levels. This can help improve circulation and maintain adequate blood pressure. The effects are typically observed shortly after administration.

Precautions & Warnings

Plasbumin 2.5 g/50mL should be handled with care and administered by healthcare professionals. It is important to follow proper storage and handling guidelines to ensure the solution remains effective. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

Plasbumin 2.5 g/50mL may interact with other medications or treatments. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of your healthcare professional regarding the use of this solution.

Frequently Asked Questions

Plasbumin 2.5 g/50mL is used to increase blood volume and treat low protein levels in the blood.

Plasbumin 2.5 g/50mL is administered intravenously by healthcare professionals.

The common effects include increased blood volume and improved circulation, which can help maintain proper blood pressure.

Yes, it should be handled and administered by healthcare professionals, and proper storage guidelines should be followed.

Yes, it may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.